1. Home
  2. NSRX vs SQNS Comparison

NSRX vs SQNS Comparison

Compare NSRX & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.08

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$3.25

Market Cap

46.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSRX
SQNS
Founded
2019
2003
Country
Israel
France
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
46.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
NSRX
SQNS
Price
$3.08
$3.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$19.67
$20.33
AVG Volume (30 Days)
20.6K
74.2K
Earning Date
03-25-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$49.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$0.73
52 Week High
$9.99
$10.93

Technical Indicators

Market Signals
Indicator
NSRX
SQNS
Relative Strength Index (RSI) 43.46 50.46
Support Level $2.78 $2.86
Resistance Level $3.58 $3.56
Average True Range (ATR) 0.22 0.23
MACD -0.05 0.03
Stochastic Oscillator 0.00 68.66

Price Performance

Historical Comparison
NSRX
SQNS

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

Share on Social Networks: